These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35548018)

  • 1. High-resolution lipidomics reveals dysregulation of lipid metabolism in respiratory syncytial virus pneumonia mice.
    Shan J; Qian W; Shen C; Lin L; Xie T; Peng L; Xu J; Yang R; Ji J; Zhao X
    RSC Adv; 2018 Aug; 8(51):29368-29377. PubMed ID: 35548018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Lipidomic and Metabolomic Analysis for Studying Metabolic Changes in Lung Tissue Induced by a Vaccine against Respiratory Syncytial Virus.
    Zardini Buzatto A; Sarkar I; van Drunen Littel-van den Hurk S; Li L
    ACS Infect Dis; 2020 Aug; 6(8):2130-2142. PubMed ID: 32633123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Network Pharmacology and Lipidomics to Reveal the Inhibitory Effect of Qingfei Oral Liquid on Excessive Autophagy in RSV-Induced Lung Inflammation.
    Lin L; An L; Chen H; Feng L; Lu M; Liu Y; Chu C; Shan J; Xie T; Wang X; Wang S
    Front Pharmacol; 2021; 12():777689. PubMed ID: 34925035
    [No Abstract]   [Full Text] [Related]  

  • 4. Label-free quantitative proteomics reveals fibrinopeptide B and heparin cofactor II as potential serum biomarkers in respiratory syncytial virus-infected mice treated with Qingfei oral liquid formula.
    Zhou LH; Xu JY; Dai C; Fan YM; Yuan B
    Chin J Nat Med; 2018 Apr; 16(4):241-251. PubMed ID: 29703324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics Investigation Reveals Metabolite Mediators Associated with Acute Lung Injury and Repair in a Murine Model of Influenza Pneumonia.
    Cui L; Zheng D; Lee YH; Chan TK; Kumar Y; Ho WE; Chen JZ; Tannenbaum SR; Ong CN
    Sci Rep; 2016 May; 6():26076. PubMed ID: 27188343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine.
    Russell MS; Creskey M; Muralidharan A; Li C; Gao J; Chen W; Larocque L; Lavoie JR; Farnsworth A; Rosu-Myles M; Hashem AM; Yauk CL; Cao J; Van Domselaar G; Cyr T; Li X
    Front Immunol; 2019; 10():597. PubMed ID: 30984178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPAR-γ in Macrophages Limits Pulmonary Inflammation and Promotes Host Recovery following Respiratory Viral Infection.
    Huang S; Zhu B; Cheon IS; Goplen NP; Jiang L; Zhang R; Peebles RS; Mack M; Kaplan MH; Limper AH; Sun J
    J Virol; 2019 May; 93(9):. PubMed ID: 30787149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of respiratory syncytial virus-related pulmonary infection on endogenous metabolites in large intestinal mucosa in mice].
    Meng X; Wang SC; Shan JJ; Xie T; Xu JY; Shen CS
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Nov; 18(11):1166-1173. PubMed ID: 27817786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic untargeted UHPLC-Q-TOF-MS based lipidomics workflow for improved detection and annotation of lipid sub-classes in serum.
    Dhariwal S; Maan K; Baghel R; Sharma A; Malakar D; Rana P
    Metabolomics; 2023 Mar; 19(4):24. PubMed ID: 36971892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A metabolomics approach to studying the effects of Jinxin oral liquid on RSV-infected mice using UPLC/LTQ-Orbitrap mass spectrometry.
    Du LN; Xie T; Xu JY; Kang A; Di LQ; Shan JJ; Wang SC
    J Ethnopharmacol; 2015 Nov; 174():25-36. PubMed ID: 26234176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Profiling of a Respiratory Syncytial Virus-Infected Rat Pneumonia Model.
    Wang XF; Zhang XY; Gao X; Liu XX; Wang YH
    Jpn J Infect Dis; 2016 Jul; 69(4):285-92. PubMed ID: 26370426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid profiles and differential lipids in serum related to severity of community-acquired pneumonia: A pilot study.
    Chen L; Zheng Y; Zhao L; Zhang Y; Yin L; He Y; Ma X; Xu Y; Gao Z
    PLoS One; 2021; 16(3):e0245770. PubMed ID: 33705428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.
    Piedimonte G
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S66-74; discussion S74-5. PubMed ID: 12671455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protectins PCTR1 and PD1 Reduce Viral Load and Lung Inflammation During Respiratory Syncytial Virus Infection in Mice.
    Walker KH; Krishnamoorthy N; Brüggemann TR; Shay AE; Serhan CN; Levy BD
    Front Immunol; 2021; 12():704427. PubMed ID: 34489955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhein Suppresses Lung Inflammatory Injury Induced by Human Respiratory Syncytial Virus Through Inhibiting NLRP3 Inflammasome Activation
    Shen C; Zhang Z; Xie T; Ji J; Xu J; Lin L; Yan J; Kang A; Dai Q; Dong Y; Shan J; Wang S; Zhao X
    Front Pharmacol; 2019; 10():1600. PubMed ID: 32047436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UHPLC-Q-Exactive Orbitrap MS/MS-based untargeted lipidomics reveals molecular mechanisms and metabolic pathways of lipid changes during golden pomfret (Trachinotus ovatus) fermentation.
    Wang H; Wu Y; Xiang H; Sun-Waterhouse D; Zhao Y; Chen S; Li L; Wang Y
    Food Chem; 2022 Dec; 396():133676. PubMed ID: 35868287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology.
    Sharma A; Wu W; Sung B; Huang J; Tsao T; Li X; Gomi R; Tsuji M; Worgall S
    J Virol; 2016 May; 90(10):5068-5074. PubMed ID: 26962219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory Viral Infection Alters the Gut Microbiota by Inducing Inappetence.
    Groves HT; Higham SL; Moffatt MF; Cox MJ; Tregoning JS
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jinxin oral liquid inhibits human respiratory syncytial virus-induced excessive inflammation associated with blockade of the NLRP3/ASC/Caspase-1 pathway.
    Shen C; Zhang Z; Xie T; Xu J; Yan J; Kang A; Dai Q; Wang S; Ji J; Shan J
    Biomed Pharmacother; 2018 Jul; 103():1376-1383. PubMed ID: 29864921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B Virus Core Particles Containing a Conserved Region of the G Protein Combined with Interleukin-35 Protected Mice against Respiratory Syncytial Virus Infection without Vaccine-Enhanced Immunopathology.
    Yang J; Ma C; Zhao Y; Fan A; Zou X; Pan Z
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.